Unknown

Dataset Information

0

DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.


ABSTRACT: BACKGROUND:Ubiquitin E3 ligase CUL4A plays important oncogenic roles in the development of cancers. DTL, one of the CUL4-DDB1 associated factors (DCAFs), may involve in the process of cancer development. Programmed cell death 4 (PDCD4) is a tumor suppressor gene involved in cell apoptosis, transformation, invasion and tumor progression. METHODS:Affinity-purification mass spectrometry was used to identify potential DTL interaction proteins. Co-immunoprecipitation (Co-IP) was performed to verify protein interaction between DTL and PDCD4. mRNA levels in cancer cells and tissues were detected by Quantitative real-time PCR. Lentivirus was used to establish stable overexpression and knocking down cell lines for DTL and PDCD4. Transwell and wound healing assays were used to determine migration ability of cancer cells. Matrigel assay was used to determine invasion ability of cancer cells. MTT and colony formation assays were used to evaluate proliferation of cancer cells. RESULTS:In this study, programmed cell death 4 (PDCD4) was identified as a potential substrate of DTL. Co-IP and immunofluorescence assays further confirmed the interaction between DTL and PDCD4. Moreover, DTL overexpression decreased the protein level and accelerated the degradation rate of PDCD4. Through in vitro ubiquitination experiment, we proved that PDCD4 was degraded by DTL through ubiquitination. Clinically DTL was significantly up-regulated in cancer tissues than that in normal tissues. The survival curves showed that cancer patients with higher DTL expression owned lower survival rate. Functional experiments showed that DTL not only enhanced the proliferation and migration abilities of cancer cells, but also promoted the tumorigenesis in nude mice. Rescued experiment results demonstrated that silencing PDCD4 simultaneous with DTL recovered the phenotypes defect caused by DTL knocking down. CONCLUSIONS:Our results elucidated that DTL enhanced the motility and proliferation of cancer cells through degrading PDCD4 to promote the development of cancers.

SUBMITTER: Cui H 

PROVIDER: S-EPMC6693180 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.

Cui Haoran H   Wang Qin Q   Lei Zhenchuan Z   Feng Maoxiao M   Zhao Zhongxi Z   Wang Yunshan Y   Wei Guangwei G  

Journal of experimental & clinical cancer research : CR 20190813 1


<h4>Background</h4>Ubiquitin E3 ligase CUL4A plays important oncogenic roles in the development of cancers. DTL, one of the CUL4-DDB1 associated factors (DCAFs), may involve in the process of cancer development. Programmed cell death 4 (PDCD4) is a tumor suppressor gene involved in cell apoptosis, transformation, invasion and tumor progression.<h4>Methods</h4>Affinity-purification mass spectrometry was used to identify potential DTL interaction proteins. Co-immunoprecipitation (Co-IP) was perfor  ...[more]

Similar Datasets

| S-EPMC10506284 | biostudies-literature
| S-EPMC8848355 | biostudies-literature
| S-EPMC4049815 | biostudies-literature
| S-EPMC8799954 | biostudies-literature
2020-12-15 | GSE163127 | GEO
| S-EPMC3179419 | biostudies-literature
| S-EPMC9254479 | biostudies-literature
| S-EPMC5835936 | biostudies-literature
| S-EPMC10096386 | biostudies-literature
| S-EPMC7281510 | biostudies-literature